Cytokine and Chemokine Profile in Patients with Multiple Myeloma Treated with Bortezomib

The aim of the study was to determine the levels of selected cytokines and chemokines in the serum of multiple myeloma (MM) patients treated with bortezomib-based regimens. A total of 71 MM patients were examined: 41 with primary refractory disease (17) or early relapse (28), and 30 who were bortezo...

Descripción completa

Detalles Bibliográficos
Autores principales: Robak, Paweł, Węgłowska, Edyta, Dróżdż, Izabela, Mikulski, Damian, Jarych, Dariusz, Ferlińska, Magdalena, Wawrzyniak, Ewa, Misiewicz, Małgorzata, Smolewski, Piotr, Fendler, Wojciech, Szemraj, Janusz, Robak, Tadeusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294367/
https://www.ncbi.nlm.nih.gov/pubmed/32587468
http://dx.doi.org/10.1155/2020/1835836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294367/
https://www.ncbi.nlm.nih.gov/pubmed/32587468
http://dx.doi.org/10.1155/2020/1835836

Ejemplares similares